Characteristics of patients with COVID-19 who have deteriorating chest X-ray findings within 48 h: a retrospective cohort study

Author:

Kusumoto Tatsuya,Chubachi Shotaro,Namkoong Ho,Tanaka Hiromu,Lee Ho,Otake Shiro,Nakagawara Kensuke,Fukushima Takahiro,Morita Atsuho,Watase Mayuko,Asakura Takanori,Masaki Katsunori,Kamata Hirofumi,Ishii Makoto,Hasegawa Naoki,Harada Norihiro,Ueda Tetsuya,Ueda Soichiro,Ishiguro Takashi,Arimura Ken,Saito Fukuki,Yoshiyama Takashi,Nakano Yasushi,Mutoh Yoshikazu,Suzuki Yusuke,Edahiro Ryuya,Murakami Koji,Sato Yasunori,Okada Yukinori,Koike Ryuji,Kitagawa Yuko,Tokunaga Katsushi,Kimura Akinori,Imoto Seiya,Miyano Satoru,Ogawa Seishi,Kanai Takanori,Fukunaga Koichi

Abstract

AbstractThe severity of chest X-ray (CXR) findings is a prognostic factor in patients with coronavirus disease 2019 (COVID-19). We investigated the clinical and genetic characteristics and prognosis of patients with worsening CXR findings during early hospitalization. We retrospectively included 1656 consecutive Japanese patients with COVID-19 recruited through the Japan COVID-19 Task Force. Rapid deterioration of CXR findings was defined as increased pulmonary infiltrates in ≥ 50% of the lung fields within 48 h of admission. Rapid deterioration of CXR findings was an independent risk factor for death, most severe illness, tracheal intubation, and intensive care unit admission. The presence of consolidation on CXR, comorbid cardiovascular and chronic obstructive pulmonary diseases, high body temperature, and increased serum aspartate aminotransferase, potassium, and C-reactive protein levels were independent risk factors for rapid deterioration of CXR findings. Risk variant at the ABO locus (rs529565-C) was associated with rapid deterioration of CXR findings in all patients. This study revealed the clinical features, genetic features, and risk factors associated with rapid deterioration of CXR findings, a poor prognostic factor in patients with COVID-19.

Funder

Precursory Research for Embryonic Science and Technology

Japan Agency for Medical Research and Development

Core Research for Evolutional Science and Technology

Ministry of Health, Labour and Welfare

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3